251 related articles for article (PubMed ID: 29895827)
1. Oxidized phospholipids regulate amino acid metabolism through MTHFD2 to facilitate nucleotide release in endothelial cells.
Hitzel J; Lee E; Zhang Y; Bibli SI; Li X; Zukunft S; Pflüger B; Hu J; Schürmann C; Vasconez AE; Oo JA; Kratzer A; Kumar S; Rezende F; Josipovic I; Thomas D; Giral H; Schreiber Y; Geisslinger G; Fork C; Yang X; Sigala F; Romanoski CE; Kroll J; Jo H; Landmesser U; Lusis AJ; Namgaladze D; Fleming I; Leisegang MS; Zhu J; Brandes RP
Nat Commun; 2018 Jun; 9(1):2292. PubMed ID: 29895827
[TBL] [Abstract][Full Text] [Related]
2. Cancer stem-like properties and gefitinib resistance are dependent on purine synthetic metabolism mediated by the mitochondrial enzyme MTHFD2.
Nishimura T; Nakata A; Chen X; Nishi K; Meguro-Horike M; Sasaki S; Kita K; Horike SI; Saitoh K; Kato K; Igarashi K; Murayama T; Kohno S; Takahashi C; Mukaida N; Yano S; Soga T; Tojo A; Gotoh N
Oncogene; 2019 Apr; 38(14):2464-2481. PubMed ID: 30532069
[TBL] [Abstract][Full Text] [Related]
3. Combinatorial targeting of MTHFD2 and PAICS in purine synthesis as a novel therapeutic strategy.
Cheung CHY; Hsu CL; Tsuei CY; Kuo TT; Huang CT; Hsu WM; Chung YH; Wu HY; Hsu CC; Huang HC; Juan HF
Cell Death Dis; 2019 Oct; 10(11):786. PubMed ID: 31624245
[TBL] [Abstract][Full Text] [Related]
4. MTHFD2 Overexpression Predicts Poor Prognosis in Renal Cell Carcinoma and is Associated with Cell Proliferation and Vimentin-Modulated Migration and Invasion.
Lin H; Huang B; Wang H; Liu X; Hong Y; Qiu S; Zheng J
Cell Physiol Biochem; 2018; 51(2):991-1000. PubMed ID: 30466107
[TBL] [Abstract][Full Text] [Related]
5. Xanthine Derivatives Reveal an Allosteric Binding Site in Methylenetetrahydrofolate Dehydrogenase 2 (MTHFD2).
Lee LC; Peng YH; Chang HH; Hsu T; Lu CT; Huang CH; Hsueh CC; Kung FC; Kuo CC; Jiaang WT; Wu SY
J Med Chem; 2021 Aug; 64(15):11288-11301. PubMed ID: 34337952
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial MTHFD isozymes display distinct expression, regulation, and association with cancer.
Nilsson R; Nicolaidou V; Koufaris C
Gene; 2019 Oct; 716():144032. PubMed ID: 31377316
[TBL] [Abstract][Full Text] [Related]
7. Suppression of MTHFD2 in MCF-7 Breast Cancer Cells Increases Glycolysis, Dependency on Exogenous Glycine, and Sensitivity to Folate Depletion.
Koufaris C; Gallage S; Yang T; Lau CH; Valbuena GN; Keun HC
J Proteome Res; 2016 Aug; 15(8):2618-25. PubMed ID: 27315223
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of MTHFD2 is associated with clinicopathological characteristics and poor survival in ovarian cancer, possibly by regulating MOB1A signaling.
Cui X; Su H; Yang J; Wu X; Huo K; Jing X; Zhang S
J Ovarian Res; 2022 Feb; 15(1):23. PubMed ID: 35135596
[TBL] [Abstract][Full Text] [Related]
9. p53 deficiency induces MTHFD2 transcription to promote cell proliferation and restrain DNA damage.
Li G; Wu J; Li L; Jiang P
Proc Natl Acad Sci U S A; 2021 Jul; 118(28):. PubMed ID: 34244426
[TBL] [Abstract][Full Text] [Related]
10. Glioma cells require one-carbon metabolism to survive glutamine starvation.
Tanaka K; Sasayama T; Nagashima H; Irino Y; Takahashi M; Izumi Y; Uno T; Satoh N; Kitta A; Kyotani K; Fujita Y; Hashiguchi M; Nakai T; Kohta M; Uozumi Y; Shinohara M; Hosoda K; Bamba T; Kohmura E
Acta Neuropathol Commun; 2021 Jan; 9(1):16. PubMed ID: 33468252
[TBL] [Abstract][Full Text] [Related]
11. Folate-mediated one-carbon metabolism: a targeting strategy in cancer therapy.
Yang C; Zhang J; Liao M; Yang Y; Wang Y; Yuan Y; Ouyang L
Drug Discov Today; 2021 Mar; 26(3):817-825. PubMed ID: 33316375
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of MTHFD2 inhibits NSCLC progression by suppressing cycle-related genes.
Yu C; Yang L; Cai M; Zhou F; Xiao S; Li Y; Wan T; Cheng D; Wang L; Zhao C; Huang X
J Cell Mol Med; 2020 Jan; 24(2):1568-1577. PubMed ID: 31778025
[TBL] [Abstract][Full Text] [Related]
13. MTHFD2 promotes ovarian cancer growth and metastasis via activation of the STAT3 signaling pathway.
Li Q; Yang F; Shi X; Bian S; Shen F; Wu Y; Zhu C; Fu F; Wang J; Zhou J; Chen Y
FEBS Open Bio; 2021 Oct; 11(10):2845-2857. PubMed ID: 34231329
[TBL] [Abstract][Full Text] [Related]
14. A novel oral inhibitor for one-carbon metabolism and checkpoint kinase 1 inhibitor as a rational combination treatment for breast cancer.
Lee J; Chen X; Wang Y; Nishimura T; Li M; Ishikawa S; Daikoku T; Kawai J; Tojo A; Gotoh N
Biochem Biophys Res Commun; 2021 Dec; 584():7-14. PubMed ID: 34753066
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of circ-MTHFD2 in diagnosis, pathological staging and prognosis of NSCLC.
Geng QQ; Wu QF; Zhang Y; Zhang GJ; Fu JK; Chen NZ
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9473-9479. PubMed ID: 33015789
[TBL] [Abstract][Full Text] [Related]
16. MTHFD2, metabolic mastermind of CD4
Gouirand V; Rosenblum MD
Sci Immunol; 2022 Mar; 7(69):eabo6765. PubMed ID: 35245088
[TBL] [Abstract][Full Text] [Related]
17. Newcastle Disease Virus Manipulates Mitochondrial MTHFD2-Mediated Nucleotide Metabolism for Virus Replication.
Tang N; Chen P; Zhao C; Liu P; Tan L; Song C; Qiu X; Liao Y; Liu X; Luo T; Sun Y; Ding C
J Virol; 2023 Mar; 97(3):e0001623. PubMed ID: 36794935
[TBL] [Abstract][Full Text] [Related]
18. MTHFD2-mediated redox homeostasis promotes gastric cancer progression under hypoxic conditions.
Mo HY; Wang RB; Ma MY; Zhang Y; Li XY; Wen WR; Han Y; Tian T
Redox Rep; 2024 Dec; 29(1):2345455. PubMed ID: 38723197
[TBL] [Abstract][Full Text] [Related]
19. NAD- and NADP-dependent mitochondrially targeted methylenetetrahydrofolate dehydrogenase-cyclohydrolases can rescue mthfd2 null fibroblasts.
Patel H; Di Pietro E; Mejia N; MacKenzie RE
Arch Biochem Biophys; 2005 Oct; 442(1):133-9. PubMed ID: 16150419
[TBL] [Abstract][Full Text] [Related]
20. Folate enzyme MTHFD2 links one-carbon metabolism to unfolded protein response in glioblastoma.
Zhu Z; Kiang KM; Li N; Liu J; Zhang P; Jin L; He X; Zhang S; Leung GK
Cancer Lett; 2022 Nov; 549():215903. PubMed ID: 36089117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]